大葉大學圖書館 |

Biologics to treat substance use disorders[electronic resource] :vaccines, monoclonal antibodies, and enzymes /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
杜威分類號:	616.86061
書名/作者:	Biologics to treat substance use disorders : vaccines, monoclonal antibodies, and enzymes // edited by Ivan D. Montoya.
其他作者:	Montoya, Ivan D.
出版者:	Cham : : Springer International Publishing :, 2016.
面頁冊數:	xvi, 453 p. : : ill., digital ;; 24 cm.
Contained By:	Springer eBooks
標題:	Substance abuse - Chemotherapy.
標題:	Biologicals.
標題:	Medicine & Public Health.
標題:	Psychopharmacology.
標題:	Pharmacotherapy.
標題:	Pharmacology/Toxicology.
ISBN:	9783319231501
ISBN:	9783319231495
內容註:	Introduction -- PART I: Vaccines: Introduction -- Nicotine -- Cocaine -- Heroin -- Metamphetamine -- PART II: Monoclonal antibodies: Introduction -- Cocaine -- Metamphetamine -- PCP -- PART III: Enzymes: Introduction -- Butyrylcholinesterase -- Cocaine Esterase -- PART IV: New strategies to optimize the development of biologics: Adenovirus based vaccines -- Nanotechnology based vaccines -- Protein Nanoparticles -- DNA Scaffolded Vaccines -- Single Hapten Conjugate Therapeutic Vaccine -- Vaccine Adjuvants -- Laser Adjuvant -- Peptide Conjugates & Cytokine Adjuvants -- T. brucei: A Platform for Immunization -- Vaccines for SUDs and HIV infection -- New Monoclonal Antibodies -- Protein Engineered for Controlled Duration of Action -- PART V: Ethical aspects of biologics to treat SUDs.
摘要、提要註:	This book is a scientific compendium documenting the state of the art in the discovery and development of vaccines, monoclonal antibodies, and enzymes for the treatment of Substance Use Disorders (SUDs) The book gives detailed consideration to some of the most cutting edge topics in addiction medicine, including vaccines for nicotine, cocaine, heroin, and methamphetamine dependence; monoclonal antibodies against cocaine, methamphetamine, and phencyclidine; and the enzymes butyrylcholinesterase and cocaine esterase. In addition, the text covers a wide range of new strategies designed to optimize the development and efficacy of biologics. Unlike any other resource, this book reviews how biologics offer exciting new therapeutic opportunities for various psychiatric conditions. Written by experts in the field, Biologics to Treat Substance Use Disorders is as an authoritative reference for psychiatrists, psychologists, and all other medical professionals working with patients suffering from Substance Use Disorders.
電子資源:	http://dx.doi.org/10.1007/978-3-319-23150-1

Biologics to treat substance use disorders[electronic resource] :vaccines, monoclonal antibodies, and enzymes /
Biologics to treat substance use disordersvaccines, monoclonal antibodies, and enzymes /[electronic resource] :edited by Ivan D. Montoya. - Cham :Springer International Publishing :2016. - xvi, 453 p. :ill., digital ;24 cm.

Introduction -- PART I: Vaccines: Introduction -- Nicotine -- Cocaine -- Heroin -- Metamphetamine -- PART II: Monoclonal antibodies: Introduction -- Cocaine -- Metamphetamine -- PCP -- PART III: Enzymes: Introduction -- Butyrylcholinesterase -- Cocaine Esterase -- PART IV: New strategies to optimize the development of biologics: Adenovirus based vaccines -- Nanotechnology based vaccines -- Protein Nanoparticles -- DNA Scaffolded Vaccines -- Single Hapten Conjugate Therapeutic Vaccine -- Vaccine Adjuvants -- Laser Adjuvant -- Peptide Conjugates & Cytokine Adjuvants -- T. brucei: A Platform for Immunization -- Vaccines for SUDs and HIV infection -- New Monoclonal Antibodies -- Protein Engineered for Controlled Duration of Action -- PART V: Ethical aspects of biologics to treat SUDs.

This book is a scientific compendium documenting the state of the art in the discovery and development of vaccines, monoclonal antibodies, and enzymes for the treatment of Substance Use Disorders (SUDs) The book gives detailed consideration to some of the most cutting edge topics in addiction medicine, including vaccines for nicotine, cocaine, heroin, and methamphetamine dependence; monoclonal antibodies against cocaine, methamphetamine, and phencyclidine; and the enzymes butyrylcholinesterase and cocaine esterase. In addition, the text covers a wide range of new strategies designed to optimize the development and efficacy of biologics. Unlike any other resource, this book reviews how biologics offer exciting new therapeutic opportunities for various psychiatric conditions. Written by experts in the field, Biologics to Treat Substance Use Disorders is as an authoritative reference for psychiatrists, psychologists, and all other medical professionals working with patients suffering from Substance Use Disorders.

ISBN: 9783319231501

Standard No.: 10.1007/978-3-319-23150-1doiSubjects--Topical Terms:

654550
Substance abuse
--Chemotherapy.

LC Class. No.: RC564

Dewey Class. No.: 616.86061

Biologics to treat substance use disorders[electronic resource] :vaccines, monoclonal antibodies, and enzymes /
LDR:02777nam a2200313 a 4500 001 455828
003 DE-He213
005 20160810085218.0
006 m d
007 cr nn 008maaau
008 161227s2016 gw s 0 eng d
020 $a 9783319231501 $q (electronic bk.)
020 $a 9783319231495 $q (paper)
024 7 $a 10.1007/978-3-319-23150-1 $2 doi
035 $a 978-3-319-23150-1
040 $a GP $c GP
041 0 $a eng
050 4 $a RC564
072 7 $a MMGW $2 bicssc
072 7 $a MED105020 $2 bisacsh
082 0 4 $a 616.86061 $2 23
090 $a RC564 $b .B615 2016
245 0 0 $a Biologics to treat substance use disorders $h [electronic resource] : $b vaccines, monoclonal antibodies, and enzymes / $c edited by Ivan D. Montoya.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2016.
300 $a xvi, 453 p. : $b ill., digital ; $c 24 cm.
505 0 $a Introduction -- PART I: Vaccines: Introduction -- Nicotine -- Cocaine -- Heroin -- Metamphetamine -- PART II: Monoclonal antibodies: Introduction -- Cocaine -- Metamphetamine -- PCP -- PART III: Enzymes: Introduction -- Butyrylcholinesterase -- Cocaine Esterase -- PART IV: New strategies to optimize the development of biologics: Adenovirus based vaccines -- Nanotechnology based vaccines -- Protein Nanoparticles -- DNA Scaffolded Vaccines -- Single Hapten Conjugate Therapeutic Vaccine -- Vaccine Adjuvants -- Laser Adjuvant -- Peptide Conjugates & Cytokine Adjuvants -- T. brucei: A Platform for Immunization -- Vaccines for SUDs and HIV infection -- New Monoclonal Antibodies -- Protein Engineered for Controlled Duration of Action -- PART V: Ethical aspects of biologics to treat SUDs.
520 $a This book is a scientific compendium documenting the state of the art in the discovery and development of vaccines, monoclonal antibodies, and enzymes for the treatment of Substance Use Disorders (SUDs) The book gives detailed consideration to some of the most cutting edge topics in addiction medicine, including vaccines for nicotine, cocaine, heroin, and methamphetamine dependence; monoclonal antibodies against cocaine, methamphetamine, and phencyclidine; and the enzymes butyrylcholinesterase and cocaine esterase. In addition, the text covers a wide range of new strategies designed to optimize the development and efficacy of biologics. Unlike any other resource, this book reviews how biologics offer exciting new therapeutic opportunities for various psychiatric conditions. Written by experts in the field, Biologics to Treat Substance Use Disorders is as an authoritative reference for psychiatrists, psychologists, and all other medical professionals working with patients suffering from Substance Use Disorders.
650 0 $a Substance abuse $x Chemotherapy. $3 654550
650 0 $a Biologicals. $3 614567
650 1 4 $a Medicine & Public Health. $3 463493
650 2 4 $a Psychopharmacology. $3 372108
650 2 4 $a Pharmacotherapy. $3 528865
650 2 4 $a Pharmacology/Toxicology. $3 463455
700 1 $a Montoya, Ivan D. $3 654549
710 2 $a SpringerLink (Online service) $3 463450
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-23150-1
950 $a Medicine (Springer-11650)